What's Going On With Candel Therapeutics Stock?
What's Going On With Candel Therapeutics Stock?
Candel Therapeutics, Inc. (NASDAQ:CADL) shares are trading higher Thursday after the company received FDA orphan drug designation for CAN-2409 for the treatment of pancreatic cancer.
Candel Therapeutics, Inc.（纳斯达克股票代码：CADL）周四股价走高，此前该公司获得了美国食品药品管理局用于治疗胰腺癌的 CAN-2409 孤儿药称号。
The Details:
细节：
"We recently reported data from the phase 2 randomized clinical trial of CAN-2409 in borderline resectable pancreatic cancer, showing that CAN-2409, when added to standard of care, more than doubled the median overall survival obtained with standard of care alone," said Paul Peter Tak, MD, PhD, CEO of Candel.
Candel 首席执行官 Paul Peter Tak 医学博士、博士表示：“我们最近报告了针对临界可切除胰腺癌的 CAN-2409 二期随机临床试验的数据，显示 CAN-2409 加到标准护理中，是仅使用标准护理获得的中位总存活率的两倍多。”
"We are pleased that the FDA has now granted Candel with both Orphan Drug and Fast Track Designation to this program, as we seek to reshape the treatment paradigm in pancreatic cancer."
“我们很高兴美国食品药品管理局现已授予Candel该计划的孤儿药和快速通道称号，因为我们正在寻求重塑胰腺癌的治疗模式。”
Candel shares are moving on heavy trading volume following the company's announcement. According to data from Benzinga Pro, more than 20.7 million shares have been traded in the session, compared to the stock's 100-day average of just over 4 million shares.
该公司宣布后，Candel的股票交易量居高不下。根据Benzinga Pro的数据，该交易日交易了超过2,070万股股票，而该股的100天平均交易量略高于400万股。
Related News: What's Going On With Chinese EV Stocks Nio And XPeng?
相关新闻： 中国电动汽车股票蔚来和小鹏怎么了？
Is CADL A Good Stock To Buy?
CADL 是一只值得买入的好股票吗？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Candel Therapeutics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投资者在决定股票是否值得买入时可以做出一些决定。除了可以在Benzinga的报价页面（例如Candel Therapeutics的页面）上找到的估值指标和价格走势外，还有一些因素，例如公司是否每季度支付股息或购买大部分股票。
These are known as capital allocation programs. Candel Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
这些被称为资本分配计划。Candel Therapeutics不支付股息，但显然有几种方法可以向股东返还价值。您可以随时在Benzinga的股息日历中搜索下一家即将派发股息的公司，并确定持有该公司股份可以获得什么样的收益率。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Candel Therapeutics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回购计划显然是不同的，而且变化很大。公司可以批准回购计划，并在回购获得批准的时间内酌情购买股票。浏览Candel Therapeutics的最新消息通常可以得出该公司最近是否批准了回购计划。回购计划通常作为股价的支撑，作为需求的支撑。
CADL Price Action: According to Benzinga Pro, Candel Therapeutics shares are up 25.1% at $6.38 at the time of publication Thursday.
CADL价格走势：根据Benzinga Pro的数据，Candel Therapeutics的股价在周四发布时上涨了25.1％，至6.38美元。
Image: Myriams-Fotos from Pixabay
图片：来自 Pixabay 的 Myriams-Fotos